Article
This Startup Is Making — and Programming — Human Cells
Wired spoke to bit.bio's CEO and CMO about reprogramming cells for therapies.
21.12.2021Content type
News
Article
bit.bio CEO features in Charles River's Laboratories Disruptor series
The Charles River's Laboratories Disruptor series celebrates the work of their innovative partners.
Article
Takeda oncology vet joins bit.bio as COO
bit.bio Chief Operating Officer Kathryn Corzo featured in Endpoints News.
Article
bit.bio adds $100M+ and members to its board of directors
This feature covers the latest fundraise and appointments to the board.
Article
bit.bio adds $100M+ investments and board of directors
bit.bio adds $100M+ to its coffers and some impressive names to its board of directors.
Article
Florian Schuster features in 300 Years of Leadership and Innovation
The book celebrates leadership and innovation and covers bit.bio's ambition to engineer the future of medicine.
Article
bit.bio featured at London Tech Week 2021
Short film showcases innovative cell reprogramming technology at event.
Article
Mice don't get Alzheimer's
Find out why animals are not always ideal when studying potential treatments for diseases like Alzheimer's.
Article
bit.bio offering a reliable and consistent source of human cells
This piece covers what's different about our cell coding approach.